Investors

Date	Name	Title	Type	Shares Traded	Price Range
Feb 15, 2012	stahl neil	Officer	Sell	21,082	107.79 - 108.09
Jan 6, 2011	vagelos p roy	Director	Automatic Sell	21,043	34.04
Mar 1, 2012	brown michael s	Director	Automatic Sell	20,000	102.65 - 104.32
Mar 1, 2012	brown michael s	Director	Option Execute	20,000	15.80 - 19.69
Apr 29, 2011	gilman alfred g	Director	Acquisition (Non Open Market)	20,000	n/a
May 2, 2011	gilman alfred g	Director	Automatic Sell	20,000	50.68 - 51.11
Feb 11, 2011	goldberg murray a	Officer	Option Execute	20,000	19.43
Jan 6, 2011	goldberg murray a	Officer	Option Execute	20,000	13.00 - 19.43
Jun 3, 2010	goldberg murray a	Officer	Option Execute	20,000	13.00
Feb 3, 2010	goldberg murray a	Officer	Option Execute	20,000	9.49 - 13.00
Jan 10, 2012	goldstein joseph l	Director	Automatic Sell	20,000	74.35 - 75.00
Jan 10, 2012	goldstein joseph l	Director	Option Execute	20,000	19.69 - 23.84
Feb 23, 2012	shooter eric m	Director	Acquisition (Non Open Market)	20,000	n/a
Feb 23, 2012	shooter eric m	Director	Sell	20,000	103.51 - 104.05
May 6, 2013	shooter eric m	Director	Sell	20,000	256.49 - 264.13
May 6, 2013	shooter eric m	Director	Option Execute	20,000	24.41 - 57.11
Jan 10, 2012	terifay robert j	Officer	Option Execute	20,000	21.34 - 21.92
Nov 21, 2012	terifay robert j	Officer	Option Execute	20,000	16.80
May 14, 2010	vagelos p roy	Director	Sell	20,000	26.96 - 27.19
Sep 4, 2012	roberts william	Officer	Acquisition (Non Open Market)	19,947	n/a
Showing 161-180 of 638 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.